2-aminoethyl-benzofuran derivatives, preparation thereof and
therapeutical use thereof
    1.
    发明授权
    2-aminoethyl-benzofuran derivatives, preparation thereof and therapeutical use thereof 失效
    2-氨基乙基 - 苯并呋喃衍生物,其制备及其治疗用途

    公开(公告)号:US6063810A

    公开(公告)日:2000-05-16

    申请号:US125947

    申请日:1998-08-31

    CPC分类号: C07D307/79

    摘要: Compounds of formula (I), wherein A is a hydrogen atom or a hydroxyl group; B is a hydrogen atom or a C.sub.1-8 alkyl, C.sub.1-8 alkenyl, C.sub.1-8 fluoroalkyl or C.sub.1-8 perfluoroalkyl group; each of R.sub.1, R.sub.2 and R.sub.5, which are the same or different, is a hydrogen atom, a halogen such as chlorine, bromine or fluorine, a C.sub.1-8 alkyl, C.sub.1-8 alkenyl, C.sub.3-8 cycloalkyl, C.sub.3-8 cycloalkenyl, C.sub.6, C.sub.10 or C.sub.14 aryl, C.sub.1-6 alkoxycarbonyl, C.sub.1-6 hydroxyalkyl, C.sub.1-6 alkoxyalkyl, C.sub.1-6 alkoxy, C.sub.1-8 fluoroalkyl or C.sub.1-8 perfluoroalkyl group, or R.sub.1 and R.sub.2 taken together form a C.sub.3-8 cycloalkyl, C.sub.3-8 cycloalkenyl or C.sub.6, C.sub.10 or C.sub.14 aryl ring, except for compounds in which R.sub.1 and R.sub.2 are both hydrogen; each of R.sub.3 and R.sub.4, which are the same or different, is a hydrogen atom or a C.sub.1-8 alkyl, C.sub.1-8 alkenyl, C.sub.3-8 cycloalkyl or C.sub.3-8 cycloalkenyl group, or R.sub.3 and R.sub.4 taken together form a C.sub.2-6 cycloalkyl or C.sub.3-6 cycloalkenyl ring, e.g., piperidyl, azetidinyl or pyrrolidyl; in the form of enantiomers, diastereoisomers or mixtures thereof, including racemic mixtures;, as well as pharmaceutically acceptable acid addition salts thereof. The compounds may be used in therapy.

    摘要翻译: PCT No.PCT / FR97 / 00383 Sec。 371日期1998年8月31日 102(e)日期1998年8月31日PCT 1997年3月5日PCT公布。 公开号WO97 / 32870 日期:1997年9月12日,式(I)的化合物,其中A为氢原子或羟基; B是氢原子或C 1-8烷基,C 1-8烯基,C 1-8氟烷基或C 1-8全氟烷基; R 1,R 2和R 5各自相同或不同,为氢原子,卤素如氯,溴或氟,C 1-8烷基,C 1-8烯基,C 3-8环烷基,C 3-8环烯基 ,C 6,C 10或C 14芳基,C 1-6烷氧基羰基,C 1-6羟基烷基,C 1-6烷氧基烷基,C 1-6烷氧基,C 1-8氟代烷基或C 1-8全氟烷基,或者R 1和R 2一起形成C 3-8 环烷基,C3-8环烯基或C6,C10或C14芳基环,其中R1和R2均为氢的化合物; R 3和R 4各自相同或不同,为氢原子或C 1-8烷基,C 1-8烯基,C 3-8环烷基或C 3-8环烯基,或者R 3和R 4一起形成C2- 6环烷基或C 3-6环烯基环,例如哌啶基,氮杂环丁烷基或吡咯烷基; 以对映异构体,非对映异构体或其混合物的形式,包括外消旋混合物,以及其药学上可接受的酸加成盐。 该化合物可用于治疗。

    Cyclohexyl(alkyl)propanolamines, preparation method and pharmaceutical compositions containing same

    公开(公告)号:US07419974B2

    公开(公告)日:2008-09-02

    申请号:US11464537

    申请日:2006-08-15

    摘要: The present invention relates to the compounds of formula (I): in which A is a group of formula (a) or (b) in which R represents a hydrogen or halogen atom, an —S(O)z(C1-C4)alkyl group, an —NHSO2(C1-C4)alkyl group, an —SO2NH(C1-C4)alkyl group, an —NHSO2phenyl-(C1-C4)alkyl group or an —NHSO2phenyl group, said phenyl possibly being substituted with a halogen atom, with a (C1-C4)alkyl group or with a (C1-C4)alkoxy group; R1 represents a hydrogen atom or a (C1-C4)alkyl group, a —CO(C1-C4)alkyl group, a phenyl-(C1-C4)alkyl group or a —COphenyl group, said phenyl also possibly being substituted with a halogen atom or with a (C1-C4)alkoxy group; R2 is a hydrogen atom or an —SO2(C1-C4)alkyl group, an —SO2phenyl-(C1-C4)alkyl group or an —SO2phenyl group; X completes a ring of 5 to 8 atoms, said ring being saturated or unsaturated, possibly being substituted with one or two (C1-C4)alkyl groups and bearing one or two carbonyl groups; n, m and z are, independently, 0, 1 or 2; R3 represents a hydrogen or halogen atom, a (C1-C6)alkyl group, a (C1-C4)alkoxy group, a —COO(C1-C4)alkyl group, a —CO(C1-C4)alkyl group, an —NHSO2(C1-C4)alkyl group, an —NHSO2phenyl-(C1-C4)alkyl groups, —NO2, —CN, —CONR4R5, —COOH, or a 4,5-dihydro-1,3-oxazol-2-yl or 4,4-dimethyl-4,5-dihydro-1,3-oxazol-2-yl group; R4 and R5 represent, independently, a hydrogen atom, a phenyl, a (C1-C4)alkyl group or a phenyl-(C1-C4)alkyl group or R4 and R5 with the nitrogen atom to which they are attached, may form a ring of 5 to 7 atoms in total; and to the salts or solvates thereof, to the pharmaceutical compositions containing them, to a process for the preparation thereof and to intermediates in this process.

    Method for producing glass sheets using flotation
    5.
    发明授权
    Method for producing glass sheets using flotation 失效
    使用浮选制造玻璃板的方法

    公开(公告)号:US6089043A

    公开(公告)日:2000-07-18

    申请号:US952215

    申请日:1998-04-09

    CPC分类号: C03B18/06

    摘要: The present invention relates to a process for the manufacture of glass sheets, according to which molten glass is poured into a liquid support which is denser than the glass to form a glass strip. The glass strip is drawn and is accompanied in its movement using a continuous and flexible guiding element made of a solid material capable of adhering to the molten glass, the elements being brought into contact with the side edges of the strip. The product (P) of the value (s) of the speed of the strip and of the value (t) of its final thickness is less than 2.5.times.10.sup.-4 m.sup.2 s.sup.-1. The process makes it possible to obtain thin glass sheets exhibiting a constant thickness and a satisfactory optical quality.

    摘要翻译: PCT No.PCT / FR97 / 00555 Sec。 371日期:1998年4月9日 102(e)1998年4月9日PCT 1997年3月27日PCT公布。 公开号WO97 / 37945 PCT 日期1997年10月16日本发明涉及一种玻璃板的制造方法,根据该方法,将熔融玻璃倒入比玻璃更密的液体载体中以形成玻璃带。 玻璃带被拉伸并伴随其运动,使用由能够粘附到熔融玻璃上的固体材料制成的连续且柔性的引导元件,元件与条的侧边缘接触。 带材的速度值和其最终厚度的值(t)的乘积(P)小于2.5×10 -4 m 2·s -1。 该方法可以获得具有恒定厚度和令人满意的光学质量的薄玻璃板。

    Cyclohexyl(alkyl)propanolamines, preparation method and pharmaceutical compositions containing same

    公开(公告)号:US07622460B2

    公开(公告)日:2009-11-24

    申请号:US12144843

    申请日:2008-06-24

    摘要: The present invention relates to the compounds of formula (I): in which A is a group of formula (a) or (b) in which R represents a hydrogen or halogen atom, an —S(O)z(C1-C4)alkyl group, an —NHSO2(C1-C4)alkyl group, an —SO2NH(C1-C4)alkyl group, an —NHSO2phenyl-(C1-C4)alkyl group or an —NHSO2phenyl group, said phenyl possibly being substituted with a halogen atom, with a (C1-C4)alkyl group or with a (C1-C4)alkoxy group; R1 represents a hydrogen atom or a (C1-C4)alkyl group, a —CO(C1-C4)alkyl group, a phenyl-(C1-C4)alkyl group or a —COphenyl group, said phenyl also possibly being substituted with a halogen atom or with a (C1-C4)alkoxy group; R2 is a hydrogen atom or an —SO2(C1-C4)alkyl group, an —SO2phenyl-(C1-C4)alkyl group or an —SO2phenyl group; X completes a ring of 5 to 8 atoms, said ring being saturated or unsaturated, possibly being substituted with one or two (C1-C4)alkyl groups and bearing one or two carbonyl groups; n, m and z are, independently, 0, 1 or 2; R3 represents a hydrogen or halogen atom, a (C1-C6)alkyl group, a (C1-C4)alkoxy group, a —COO(C1-C4)alkyl group, a —CO(C1-C4)alkyl group, an —NHSO2(C1-C4)alkyl group, an —NHSO2phenyl-(C1-C4)alkyl groups, —NO2, —CN, —CONR4R5, —COOH, or a 4,5-dihydro-1,3-oxazol-2-yl or 4,4-dimethyl-4,5-dihydro-1,3-oxazol-2-yl group; R4 and R5 represent, independently, a hydrogen atom, a phenyl, a (C1-C4)alkyl group or a phenyl-(C1-C4)alkyl group or R4 and R5 with the nitrogen atom to which they are attached, may form a ring of 5 to 7 atoms in total; and to the salts or solvates thereof, to the pharmaceutical compositions containing them, to a process for the preparation thereof and to intermediates in this process.

    Compositions of silico-sodo-calcic glasses and their applications
    10.
    发明授权
    Compositions of silico-sodo-calcic glasses and their applications 失效
    硅藻石眼镜组合及其应用

    公开(公告)号:US5776844A

    公开(公告)日:1998-07-07

    申请号:US646337

    申请日:1996-12-13

    摘要: This invention concerns a thermally stable glass composition, which comprises the following constituents in the following proportions by weight: ______________________________________ SiO.sub.2 45 to 68% Al.sub.2 O.sub.3 0 to 20% ZrO.sub.2 0 to 20% B.sub.2 O.sub.3 0 to 10% Na.sub.2 O 2 to 12% K.sub.2 O 3.5 to 9% CaO 1 to 13% MgO 0 to 8% ______________________________________ the sum of the contents of the oxides SiO.sub.2, Al.sub.2 O.sub.3 and ZrO.sub.2 remaining equal to or less than 70%, the sum of the oxides Al.sub.2 O.sub.3 and ZrO.sub.2 being equal to or greater than 2%, the sum of the alkaline oxides Na.sub.2 O and K.sub.2 O being equal to or greater than 8%, said composition comprising, if desired, the oxides BaO and/or SrO in proportions such that: 11%.ltoreq.MgO+CaO+BaO+SrO

    摘要翻译: PCT No.PCT / FR95 / 01347 Sec。 371日期1996年12月13日第 102(e)日期1996年12月13日PCT提交1995年10月13日PCT公布。 公开号WO96 / 11887 日期1996年04月25日本发明涉及一种热稳定性玻璃组合物,其包含以下重量比的以下组分:SiO 2 45至68%Al 2 O 3 0至20%ZrO 2 0至20%-B 2 O 3 0至10% - Na2O 2〜12% - K2O 3.5〜9% - CaO 1〜13% - MgO 0〜8% - 氧化物SiO 2,Al 2 O 3和ZrO 2的含量之和等于或小于70% 氧化物Al 2 O 3和ZrO 2等于或大于2%,碱性氧化物Na 2 O和K 2 O的总和等于或大于8%,如果需要,所述组合物包含氧化物BaO和/或SrO,其比例使得 :11%